Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Valneva SE
  6. Summary
    VLA   FR0004056851

VALNEVA SE

(VLA)
  Report
Real-time Euronext Paris  -  05:23 2022-09-30 am EDT
5.120 EUR   +0.39%
02:09aValneva Prices Upsized $101 Million Global Offering to Fund Vaccines Developments
MT
01:12aValneva Announces Pricing of €102.9 Million Global Offering of American Depositary Shares and Ordinary Shares
GL
01:12aValneva Announces Pricing of €102.9 Million Global Offering of American Depositary Shares and Ordinary Shares
GL
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
09/26/2022 09/27/2022 09/28/2022 09/29/2022 09/30/2022 Date
5.74(c) 5.702(c) 5.78(c) 5.1(c) 5.12 Last
708 988 259 637 236 956 1 205 855 352 712 Volume
+1.09% -0.66% +1.37% -11.76% +0.39% Change
More quotes
Estimated financial data (e)
Sales 2022 338 M 330 M 330 M
Net income 2022 -44,1 M -43,1 M -43,1 M
Net cash position 2022 208 M 203 M 203 M
P/E ratio 2022 -12,9x
Yield 2022 -
Sales 2023 222 M 217 M 217 M
Net income 2023 -21,4 M -20,9 M -20,9 M
Net cash position 2023 194 M 190 M 190 M
P/E ratio 2023 -27,9x
Yield 2023 -
Capitalization 598 M 584 M 584 M
EV / Sales 2022 1,15x
EV / Sales 2023 1,82x
Nbr of Employees 700
Free-Float 68,2%
More Financials
Company
Valneva SE is a company specialized in the development and marketing of prophylactic vaccines against infectious diseases generating important medical needs. Valneva SE has a highly specialized and targeted approach and uses its expertise in different modes of vaccination to develop prophylactic vaccines to fight these diseases. Valneva SE has leveraged its expertise and infrastructure to commercialize three... 
More about the company
Ratings of Valneva SE
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about VALNEVA SE
02:09aValneva Prices Upsized $101 Million Global Offering to Fund Vaccines Developments
MT
01:12aValneva Announces Pricing of €102.9 Million Global Offering of American Depositary Shar..
GL
01:12aValneva Announces Pricing of €102.9 Million Global Offering of American Depositary Shar..
GL
09/29Sector Update: Health Care Stocks Decline Pre-Bell Thursday
MT
09/29Valneva to Raise $40 Million via Global Offering
MT
09/29Valneva Plans $40 Million Capital Raise From Global Share Offering
MT
09/28Valneva Announces Launch of Approximately $40 Million in a Proposed Global Offering of ..
GL
09/28Valneva Announces Launch of Approximately $40 Million in a Proposed Global Offering of ..
GL
09/26Valneva Says It Is in Active Discussions With Prospective Partner to Develop Second-Gen..
MT
09/26Valneva In Talks With Potential Partner For Development Of Second-generation COVID-19 V..
MT
09/26Valneva in talks with potential partner on second-gen COVID-19 vaccines
RE
09/26Talks on second-gen COVID vaccine could fail, Valneva warns
RE
09/26Valneva Provides Further Update on its COVID-19 Activities
GL
09/26Valneva Provides Further Update on its COVID-19 Activities
GL
09/23Goldman Sachs Downgrades Valneva to Neutral From Buy
MT
More news
News in other languages on VALNEVA SE
03:52aValneva : un nouvel actionnaire rentre au capital à la suite du placement privé
03:15aBolsa de Madrid: Inversores en posición lateral de seguridad
03:04aLes investisseurs en PLS
02:43aEn direct des marchés : Société Générale, Thales, Atos, EDF, GTT, ..
02:27aLe CAC 40 est attendu en légère hausse avant l'inflation dans la zone euro
More news
Analyst Recommendations on VALNEVA SE
More recommendations
ETFs positioned on VALNEVA SEETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
IShares Genomics Immunology and Healthcare ...1.58%-0.80%World
Lyxor CAC Mid 60 - Dist - EUR0.67%-5.30%France
Lyxor MSCI EMU Small Cap (DR) - Dist - EUR0.21%-6.55%Europe
UBS ETF - MSCI EMU Small Cap A-dis - EUR0.2%0.00%Europe
IShares MSCI Europe Small-Cap ETF - USD0.06%-7.35%Europe
More ETFs positioned on VALNEVA SE
Chart VALNEVA SE
Duration : Period :
Valneva SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VALNEVA SE
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 5,10 €
Average target price 12,70 €
Spread / Average Target 149%
EPS Revisions
Managers and Directors
Thomas Lingelbach Co-President & Chief Executive Officer
Franck Charles Marie Grimaud Co-President & Chief Business Officer
Peter Buhler Chief Financial Officer
Frédéric Grimaud Chairman-Supervisory Board
Michael Möhlen Vice President-Technical Development
Sector and Competitors
1st jan.Capi. (M$)
VALNEVA SE-79.18%584
MODERNA, INC.-53.51%46 189
LONZA GROUP AG-38.51%35 456
IQVIA HOLDINGS INC.-35.63%33 872
ALNYLAM PHARMACEUTICALS, INC.24.28%25 132
SEAGEN INC.-12.23%25 028